North China Pharmaceutical net profit surges 72%

North China Pharmaceutical reported net profit attributable to shareholders surged 71.56% to 123.50 million yuan for H1 2025, despite operating revenue rising just 0.84% to 5.28 billion yuan.

The company attributed the profit growth to improved budget control, lean management, and decreased procurement costs. It also issued 500 million yuan in short-term financing bonds in May.